Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 8;4(2):255-258.
doi: 10.1002/lio2.229. eCollection 2019 Apr.

Heliox for inducible laryngeal obstruction (vocal cord dysfunction): A systematic literature review

Claire Slinger  1 , Richard Slinger  2 , Aashish Vyas  1 , Jemma Haines  3 , Stephen J Fowler  4
Affiliations
Review

Heliox for inducible laryngeal obstruction (vocal cord dysfunction): A systematic literature review

Claire Slinger et al. Laryngoscope Investig Otolaryngol. .

Abstract

Objectives: To perform a systematic literature review on the use of Heliox with patients with inducible laryngeal obstruction/vocal cord dysfunction to: i) identify current evidence base; and ii) establish the methodological quality of published research.

Methods: Articles published up to March 2018 were searched for key words and terms using Cochrane Library, MEDLINE, PubMed, CINAHL, EMBASE and Dynamed. Studies were included if they presented original research into the use of Heliox for vocal cord dysfunction.

Results: Only three studies met the inclusion criteria for review. All reported favorable results for the use of Heliox as an adjunctive therapy for vocal cord dysfunction but none had sufficient methodological quality to support their conclusions.

Conclusion: Despite review articles recommending the use of Heliox in vocal cord dysfunction, there is a lack of good quality research to support this conclusion. There is a need for further research to investigate the effectiveness of Heliox as an adjunctive therapy for vocal cord dysfunction.

Level of evidence: 4.

Keywords: Heliox; VCD; iLO; inducible laryngeal obstruction; vocal cord dysfunction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Literature Search Strategy Using PRISMA Flowchart.
See this image and copyright information in PMC

References

    1. Kenn K, Balkissoon R. Vocal cord dysfunction: what do we know? Eur Respir J 2011;37:194–200. - PubMed
    1. Weir M. Vocal cord dysfunction mimics asthma and may respond to Heliox. Clin Pediatr (Phila) 2002;41(1):37–41. - PubMed
    1. Low K, Lau KK, Holmes P, et al. Abnormal vocal cord function in difficult‐to‐treat asthma. Am J Respir Crit Care Med 2011;184(1):50–56. - PubMed
    1. Newman KB, Mason UG, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995;152:1382–1386. - PubMed
    1. Christensen PM, Heimdal J, Christopher KL, et al. ERS/ELS/ACCP 2013 international consensus conference nomenclature on inducible laryngeal obstructions. Eur Respir Rev 2015;24:445–450. - PMC - PubMed

LinkOut - more resources